default author photo

Han Qi

Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy

Guangzhou, 510060

China

SCHOLARLY PAPERS

1

DOWNLOADS

50

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Neoadjuvant Toripalimab with Chemotherapy is Feasible for Resectable Stage III Non-Small-Cell Lung Cancer: A Single-Arm, Phase 2 Trial

Number of pages: 30 Posted: 12 May 2021
Ze-Rui Zhao, Chao-Pin Yang, Si Chen, Yong-Bin Lin, Yao-Bin Lin, Han Qi, Jietian Jin, Shan-Shan Lian, Yi-Zhi Wang, Wen-Yu Zhai and Hui Yu
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-Sen University (SYSU) - Department of Biotherapy, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Radiology, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 50 (1,063,489)
Citation 1

Abstract:

Loading...

lung cancer; neoadjuvant; immunotherapy; chemotherapy; toripalimab; stage III